2024 UK Hospital Hemostasis Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Forecasts, Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

October 2024 | - | ID: 2C56F57E340BEN
Venture Planning Group

Abstracts

This new report from LeadingMarketResearch.com presents a comprehensive analysis of the UK hospital Hemostasis Diagnostic testing market, including:

• Major issues pertaining to the UK coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.

• Volume and sales forecasts for 40 coagulation procedures performed in UK hospitals, including typical coagulation daily work loads.

• Review of current instrumentation technologies, and a feature comparison of leading analyzers.

• Reagent and instrument sales forecasts.

• Sales and market shares of leading reagent and instrument suppliers.

• Review of coagulation technologies and their potential market applications.

• Major opportunities for coagulation instruments and consumables.

• Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

• Business opportunities and strategic recommendations for instrument and reagent suppliers.

Contents

Worldwide Market and Technology Overview
A. Major Routine and Special Coagulation Tests

1. INTRODUCTION

2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)

3. ALPHA-2 ANTIPLASMIN

4. ANTITHROMBIN III

5. BLEEDING TIME

6. D-DIMER

7. ETHANOL FLOCCULATION TEST

8. EUGLOBULIN LYSIS

9. FACTOR ASSAYS

a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII

10. FIBRIN DEGRADATION PRODUCTS

11. FIBRINOGEN

12. HEPARIN

13. HIRUDIN

14. HYPERCOAGULABILITY AND THROMBOSIS

15. LIPOPROTEIN A

16. PLASMIN

17. PLASMINOGEN

18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)

19. PLATELET FUNCTION TESTS

20. PLATELET AGGREGATION

Table of Contents (continued)

21. PROTEINS C AND S

22. PROTHROMBIN FRAGMENT 1.2

23. PROTHROMBIN TIME (PT)

24. REPTILASE TIME

25. THROMBIN TIME

26. TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA)

27. VON WILLEBRAND'S FACTOR

B. Instrumentation: Review of latest analyzers from Bio/Data, Cardiovascular
Diagnostics, Diagnostica Stago, Helena Laboratories, Instrumentation Laboratory,
NexusDx, Roche Diagnostics, Siemens Healthineers, Sysmex, and Teco
Diagnostics.
C. Major in Vitro Diagnostic Technologies And Their
Potential Applications

1. CHROMOGENIC SUBSTRATES

2. MONOCLONAL AND POLYCLONAL ANTIBODIES

3. IMMUNOASSAYS

a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation

4. MICROCOMPUTERS

5. AUTOMATION

6. ROBOTICS

7. DNA PROBES

a. Overview
b. Amplification Methods
Table of Contents (continued)
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT

8. ARTIFICIAL INTELLIGENCE

9. DRY CHEMISTRY

10. BIOSENSORS

D. Market Overview

1. BUSINESS ENVIRONMENT

2. MARKET STRUCTURE

3. MARKET SIZE AND GROWTH

4. POC TESTING MARKET

Country Analysis
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

1. MARKETING APPROACHES

2. PRODUCT COMPLEXITY

3. CUSTOMER PREFERENCE

4. ESTABLISHED SUPPLIERS

5. EMERGING SUPPLIERS

6. MAJOR TYPES OF DISTRIBUTORS

7. MARKET SEGMENTATION

Table of Contents (continued)
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Chrono-Log
Corgenix
Diagnostica Stago
Grifols
Helena Laboratories
HYPHEN BioMed
Instrumentation Laboratory/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sienco
Sysmex
Thermo Fisher